ID
31489
Description
Study ID: 104619 Clinical Study ID: 63129 Study Title:A multinational, randomized, double-blind comparison of once daily subcutaneous fondaparinux sodium with placebo for the prevention of venous thromboembolic events in acutely ill medical patients (ARTEMIS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fondaparinux sodium Trade Name: Arixtra Study Indication: Thrombosis, Venous
Keywords
Versions (1)
- 8/28/18 8/28/18 -
Copyright Holder
GlaxoSmithKline
Uploaded on
August 28, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Subcutaneous fondaparinux sodium for prevention of venous thromboembolic events; Study ID: 104619
Similar models
Unusual Bleeding Form
- StudyEvent: ODM
C0574845 (UMLS CUI [1,2])
C1518404 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,3])
C0005841 (UMLS CUI [1,2])
C0035110 (UMLS CUI [1,2])
C0332850 (UMLS CUI [1,2])
C0184661 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,4])
No comments